menu
    • menu

    Company profile for Noramco

    Noramco-PSE
    News
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Normaco

    Contact Supplier

    Website

    Arab Health

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/NUY-WJrSlVU

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Related CompaniesRelated Companies

    About

    Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NoramcoUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Swedes Landing Rd, Wilmington, DE 19801
    Telephone
    Telephone
    +1 3026523840
    Client Email
    Email
    aambrosi@Noramco.com
    Client Website
    Website
    https://www.noramco.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/noramco-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-87243.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-64446.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DMF Submitted for Lisdexamfetamine Dimesylate API

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1638594073.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Small Volume Manufacture of APIs 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582542575.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Reference Standards List 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582615883.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Diversifying the Supply of Raw Materials
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/06/12/diversifying-the-supply-of-raw-materials/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/03/14/noramco-announces-strategic-alignment-with-purisys-and-halo-pharma/

    PRESS RELEASE
    15 Mar 2024
    Share Share
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    https://www.noramco.com/2023/11/02/noramco-announces-the-acquisition-of-the-cambrex-drug-product-business-unit/

    PRESS RELEASE
    02 Nov 2023
    Share Share
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

    01 Nov 2022

    // PRESS RELEASE

    https://www.noramco.com/2022/11/01/noramco-announces-submission-and-reactivation-of-the-drug-master-file-for-active-pharmaceutical-ingredient-methylnaltrexone-bromide/

    PRESS RELEASE
    01 Nov 2022
    Share Share
    Noramco Celebrates Diversity and International Women’s Day
    Noramco Celebrates Diversity and International Women’s Day

    07 Mar 2022

    // Randolph Ramirez PRESS RELEASE

    https://www.noramco.com/2022/03/07/noramco-celebrates-diversity-and-international-womens-day/

    Randolph Ramirez PRESS RELEASE
    07 Mar 2022
    Share Share
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate

    03 Dec 2021

    // PRESS RELEASE

    https://www.noramco.com/2021/12/03/noramco-lisdexamfetamine-dmf-submission/

    PRESS RELEASE
    03 Dec 2021
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Buprenorphine

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-15

    Pay. Date : 2012-11-23

    DMF Number : 23684

    Submission : 2010-04-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2007-190 - Rev 05

    Issue Date : 2024-06-20

    Type : Chemical

    Substance Number : 1180

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Buprenorphine Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-23

    Pay. Date : 2012-11-23

    DMF Number : 23683

    Submission : 2010-04-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2010-142 - Rev 05

    Issue Date : 2023-08-23

    Type : Chemical

    Substance Number : 1181

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-0608

    Start Marketing Date : 2017-07-26

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Hydromorphone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-06

    Pay. Date : 2012-11-23

    DMF Number : 19561

    Submission : 2006-06-29

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-169 - Rev 04

    Issue Date : 2021-03-25

    Type : Chemical

    Substance Number : 2099

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-0057

    Start Marketing Date : 2006-06-29

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Methylphenidate Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-03-27

    Pay. Date : 2012-11-23

    DMF Number : 22244

    Submission : 2008-12-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2018-030 - Rev 04

    Issue Date : 2024-09-26

    Type : Chemical

    Substance Number : 2235

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-0114

    Start Marketing Date : 2017-07-31

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Naloxone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-06-14

    Pay. Date : 2012-12-07

    DMF Number : 24633

    Submission : 2011-02-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-125 - Rev 01

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 729

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Naloxone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-09-03

    Pay. Date : 2014-10-14

    DMF Number : 28226

    Submission : 2014-08-13

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-055 - Rev 03

    Issue Date : 2023-09-06

    Type : Chemical

    Substance Number : 729

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Naltrexone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-01-14

    Pay. Date : 2013-12-20

    DMF Number : 23325

    Submission : 2009-12-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-291 - Rev 02

    Issue Date : 2024-04-23

    Type : Chemical

    Substance Number : 1790

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-1064

    Start Marketing Date : 2024-01-05

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Oxycodone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-04-16

    Pay. Date : 2013-04-05

    DMF Number : 16399

    Submission : 2003-02-03

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-058 - Rev 04

    Issue Date : 2022-05-12

    Type : Chemical

    Substance Number : 1793

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-0002

    Start Marketing Date : 2000-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Samung Industrial Co., Ltd.

    Registration Date : 2024-01-26

    Registration Number : 20240126-209-J-1599

    Manufacturer Name : Noramco, LLC

    Manufacturer Address : 500 Swedes Landing Road Wilmington, Delaware 19801

     VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Oxycodone Hydrochloride

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-12-27

    Pay. Date : 2012-11-23

    DMF Number : 20975

    Submission : 2007-10-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-284 - Rev 02

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 1793

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51634-0002

    Start Marketing Date : 2000-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Samung Industrial Co., Ltd.

    Registration Date : 2024-01-26

    Registration Number : 20240126-209-J-1599

    Manufacturer Name : Noramco, LLC

    Manufacturer Address : 500 Swedes Landing Road Wilmington, Delaware 19801

     VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Tetrahydrocannabinol

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19335

    Submission : 2006-04-07

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    REF. STANDARDS & IMPURITIES

    Check the ref. standards & impurities from this company

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Noramco and get a quotation

    Noramco is a supplier offers 26 products (APIs, Excipients or Intermediates).

    Find a price of Buprenorphine bulk with DMF, CEP offered by Noramco

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Hydromorphone Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Methylphenidate Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Oxycodone Hydrochloride bulk with DMF, CEP offered by Noramco

    Find a price of Buprenorphine bulk with DMF offered by Noramco

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Noramco

    Find a price of Codeine Phosphate bulk with DMF offered by Noramco

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Noramco

    Find a price of Levorphanol Tartrate bulk with DMF offered by Noramco

    Find a price of Lisdexamfetamine Dimesylate bulk with DMF offered by Noramco

    Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Noramco

    Find a price of Morphine Sulfate bulk with DMF offered by Noramco

    Find a price of Naltrexone bulk with DMF offered by Noramco

    Find a price of Naltrexone Methobromide bulk with DMF offered by Noramco

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Noramco

    Find a price of Oxymorphone Hydrochloride bulk with DMF offered by Noramco

    Find a price of Tapentadol bulk with DMF offered by Noramco

    Find a price of Cannabidiol bulk offered by Noramco

    Find a price of Dexmethylphenidate bulk offered by Noramco

    Find a price of Nabilone bulk offered by Noramco

    Find a price of Oxymorphone bulk offered by Noramco

    Find a price of Sodium Oxybate bulk offered by Noramco

    Find a price of Tetrahydrocannabinol bulk offered by Noramco

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search